Diana Santo Domingo, MD
Dermatology · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Office
- 1
Offices
1 location · Berman Skin Institute Medical Group Inc · 26 clinicians in this group
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Domingo’s office at (925) 416-1122 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence C168169 · Current
Licensed to practise in California · since 2020 · expires 2028-03-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$20,457
Medicare paid this office $20,457 for 131 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (30+ min) | 36 | $3,043 | $85 |
| Biopsy of related skin growth, first growth | 32 | $2,848 | $89 |
| Destruction of skin growth, 1-14 growths | 29 | $2,766 | $89 |
| Short return visit (20+ min) | 42 | $2,746 | $60 |
| Destruction of precancer skin growth, 1 growth | 41 | $2,043 | $43 |
See all 8 services
| New patient visit (30+ min) | 36 | $3,043 | $85 |
| Biopsy of related skin growth, first growth | 32 | $2,848 | $89 |
| Destruction of skin growth, 1-14 growths | 29 | $2,766 | $89 |
| Short return visit (20+ min) | 42 | $2,746 | $60 |
| Destruction of precancer skin growth, 1 growth | 41 | $2,043 | $43 |
| Return visit (30+ min) | 12 | $1,742 | $109 |
| Destruction of precancer skin growth, 2-14 growths | 30 | $1,217 | $6 |
| Short return visit | 19 | $634 | $33 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
131 Original Medicare patients in 2024. Average age 74 · Women 61% · Also on Medicaid 31% · Health risk score 1.12. Above the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 69% · Diabetes 33% · Coronary heart disease 24% · COPD 20% · Depression 19% · Chronic kidney disease 17% · Heart failure 13% · Cancer 13% · Atrial fibrillation 12%.
The office billed $51,444, Medicare allowed $32,145 and paid $20,457; for 453 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 131 | 453 | 74 | 1.12 | $51,444 | $20,457 |
| 2023 | 62 | 243 | 71 | 1.14 | $27,679 | $13,056 |
| 2020 | 70 | 191 | 71 | 0.96 | $40,076 | $10,708 |
| 2017 | 108 | 420 | 72 | 1.51 | $53,708 | $19,836 |
| 2016 | 99 | 491 | 71 | 1.38 | $38,960 | $20,599 |
| 2015 | 87 | 393 | 74 | 1.34 | $32,375 | $17,356 |
| 2014 | 97 | 371 | 73 | 1.41 | $32,120 | $18,310 |
| 2013 | 40 | 198 | 71 | 1.15 | $17,910 | $10,953 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| New patient visit (30+ min) | 23 | $2,365 | $103 |
| Biopsy of related skin growth, first growth | 19 | $1,764 | $93 |
| Destruction of skin growth, 1-14 growths | 13 | $1,677 | $120 |
| Short return visit (20+ min) | 17 | $1,565 | $82 |
| Destruction of precancer skin growth, 1 growth | 25 | $1,201 | $44 |
| Short return visit | 11 | $611 | $56 |
| Destruction of precancer skin growth, 2-14 growths | 19 | $608 | $7 |
2020: 4 services
| New patient visit (30+ min) | 37 | $3,028 | $82 |
| Destruction of precancer skin growth, 1 growth | 34 | $1,709 | $49 |
| Short return visit (20+ min) | 27 | $1,654 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 22 | $278 | $6 |
2017: 9 services
| Short return visit (20+ min) | 59 | $4,872 | $52 |
| Biopsy of single growth of skin and/or tissue | 39 | $3,461 | $77 |
| Return visit (30+ min) | 19 | $1,568 | $75 |
| New patient visit (15+ min) | 28 | $1,552 | $55 |
| Destruction of precancer skin growth, 1 growth | 21 | $1,369 | $41 |
| New patient visit (30+ min) | 16 | $1,292 | $81 |
| Destruction of skin growth, 1-14 growths | 13 | $1,173 | $90 |
| Biopsy of each additional growth of skin and/or tissue | 13 | $436 | $26 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $371 | $4 |
2016: 9 services
| Short return visit (20+ min) | 57 | $4,792 | $53 |
| Biopsy of single growth of skin and/or tissue | 35 | $3,331 | $77 |
| Return visit (30+ min) | 27 | $2,615 | $84 |
| New patient visit (30+ min) | 27 | $2,229 | $83 |
| Destruction of precancer skin growth, 1 growth | 34 | $1,536 | $37 |
| New patient visit (15+ min) | 11 | $654 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 29 | $535 | $4 |
| Biopsy of each additional growth of skin and/or tissue | 15 | $498 | $28 |
| Tissue fungi or parasites | 12 | $80 | $6 |
2015: 9 services
| Biopsy of single growth of skin and/or tissue | 35 | $3,150 | $81 |
| Short return visit (20+ min) | 35 | $2,626 | $53 |
| Return visit (30+ min) | 20 | $1,857 | $77 |
| New patient visit (15+ min) | 33 | $1,650 | $50 |
| Destruction of precancer skin growth, 1 growth | 31 | $1,594 | $39 |
| Destruction of skin growth, 1-14 growths | 11 | $1,008 | $84 |
| Biopsy of each additional growth of skin and/or tissue | 19 | $927 | $27 |
| Short return visit | 11 | $648 | $36 |
| Destruction of precancer skin growth, 2-14 growths | 19 | $416 | $5 |
2014: 9 services
| Biopsy of single growth of skin and/or tissue | 45 | $3,927 | $80 |
| Short return visit (20+ min) | 46 | $3,916 | $52 |
| Destruction of precancer skin growth, 1 growth | 29 | $1,844 | $47 |
| New patient visit (15+ min) | 36 | $1,813 | $50 |
| Return visit (30+ min) | 14 | $1,221 | $87 |
| New patient visit (30+ min) | 15 | $1,201 | $80 |
| Destruction of skin growth, 1-14 growths | 11 | $1,036 | $80 |
| Biopsy of each additional growth of skin and/or tissue | 20 | $845 | $27 |
| Destruction of precancer skin growth, 2-14 growths | 17 | $494 | $8 |
2013: 3 services
| Biopsy of single growth of skin and/or tissue | 22 | $2,011 | $84 |
| Short return visit (20+ min) | 22 | $1,894 | $57 |
| Destruction of precancer skin growth, 1 growth | 18 | $1,326 | $53 |
Drugs they prescribed that Part D paid
$3,739
Pharmacies billed $3,739 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 154) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
149 generic and fewer than 11 brand-name prescriptions · $3,739 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 29 | $483 | $17 |
| Fluocinonide | 11 | $436 | $40 |
| Triamcinolone Acetonide | 20 | $244 | $12 |
Year by year
| 2024 | 154 | 89 | 0% (0) | None | $3,739 |
| 2023 | 196 | 99 | 0% (0) | 9% | $64,036 |
| 2022 | 115 | 63 | 0% (0) | 11% | $68,406 |
| 2020 | 48 | 22 | 0% (0) | 0% | $1,518 |
| 2019 | 26 | 14 | 0% (0) | 0% | $552 |
| 2018 | 23 | 16 | 0% (0) | None | $606 |
| 2017 | 475 | 145 | 0% (0) | 11% | $27,798 |
| 2016 | 400 | 141 | None | 18% | $68,155 |
| 2015 | 349 | 114 | 0% (0) | 13% | $35,787 |
| 2014 | 317 | 103 | 0% (0) | 9% | $26,112 |
| 2013 | 121 | 50 | 0% (0) | 12% | $9,830 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Clobetasol Propionate | 16 | $1,629 | $102 |
| Ketoconazole | 17 | $560 | $33 |
| Triamcinolone Acetonide | 33 | $498 | $15 |
2022: 2 drugs
| Ketoconazole | 18 | $468 | $26 |
| Triamcinolone Acetonide | 16 | $192 | $12 |
2020: 1 drug
| Ketoconazole | 17 | $616 | $36 |
2017: 10 drugs
| Ketoconazole | 86 | $2,410 | $28 |
| Fluocinonide | 26 | $2,100 | $81 |
| Clobetasol Propionate | 15 | $2,001 | $133 |
| Clindamycin Phosphate | 25 | $1,466 | $59 |
| Triamcinolone Acetonide | 72 | $933 | $13 |
| Mupirocin | 32 | $477 | $15 |
| Nystatin | 26 | $360 | $14 |
| Hydrocortisone | 42 | $287 | $7 |
| Valacyclovir | 13 | $108 | $8 |
| Hydroxyzine | 13 | $95 | $7 |
2016: 12 drugs
| Elidel | 11 | $7,094 | $645 |
| Clobetasol Propionate | 29 | $3,795 | $131 |
| Clindamycin Phosphate | 33 | $2,099 | $64 |
| Metronidazole | 13 | $1,822 | $140 |
| Ketoconazole | 46 | $1,326 | $29 |
| Fluocinonide | 21 | $1,280 | $61 |
| Doxycycline Hyclate | 24 | $822 | $34 |
| Triamcinolone Acetonide | 61 | $769 | $13 |
| Ciclopirox | 15 | $457 | $30 |
| Hydrocortisone | 40 | $288 | $7 |
| Nystatin | 15 | $202 | $13 |
| Mupirocin | 16 | $146 | $9 |
2015: 8 drugs
| Clobetasol Propionate | 39 | $7,879 | $202 |
| Clindamycin Phosphate | 34 | $1,736 | $51 |
| Fluocinonide | 20 | $1,643 | $82 |
| Ketoconazole | 53 | $1,358 | $26 |
| Doxycycline Hyclate | 15 | $905 | $60 |
| Triamcinolone Acetonide | 49 | $631 | $13 |
| Nystatin | 17 | $309 | $18 |
| Hydrocortisone | 38 | $284 | $7 |
2014: 6 drugs
| Clobetasol Propionate | 42 | $2,993 | $71 |
| Triamcinolone Acetonide | 52 | $1,336 | $26 |
| Clindamycin Phosphate | 22 | $1,092 | $50 |
| Ketoconazole | 59 | $1,081 | $18 |
| Doxycycline Hyclate | 11 | $754 | $69 |
| Hydrocortisone | 36 | $239 | $7 |
2013: 4 drugs
| Clobetasol Propionate | 16 | $1,246 | $78 |
| Triamcinolone Acetonide | 20 | $476 | $24 |
| Hydrocortisone | 21 | $227 | $11 |
| Ketoconazole | 16 | $227 | $14 |
Money from drug and device companies
$104 in 2025
| 2025 | 2 | 2 | None | $104 |
| 2024 | 1 | 1 | None | $25 |
| 2023 | 2 | 3 | None | $77 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Litfulo | $84 | 1 payment
|
| Janssen Biotech | Tremfya | $20 | 1 payment
|
See all 2 published payments
| Janssen Biotech | Meals · 2025-04-01 | Tremfya | $20 |
| Pfizer | Meals · 2025-02-06 | Litfulo | $84 |
See earlier years (2024, 2023, 2019)
2024: $25
| Novartis Pharmaceuticals | Xolair | $25 | 1 payment
|
2023: $77
| Janssen Biotech | Tremfya | $48 | 2 payments
|
| Dermavant Sciences | Vtama | $29 | 1 payment
|
2019: $20
| Sun Pharmaceutical Industries | Ilumya | $20 | 1 payment
|
Professional record
- NPI
- 1437350709
- Licence
- CA 997612, CA C168169California C168169: Current · expires 2028-03-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-05-31
- NPI last updated
- 2023-09-22
- NPI record certified
- 2023-09-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 9460 N Name Uno Ste 210, Gilroy, CA, 95020 · 603 N Flamingo Rd, Pembroke Pines, FL, 33028